From L-R: Reps. Raja Krishnamoorthi (D-IL) and Mike Gallagher (R-WI), and Ginkgo co-founder Tom Knight at Ginkgo's headquarters on Feb. 13, 2024, discussing Chinese competition in biotech (Nicole DeFeudis for Endpoints News)
March 7, 2024 03:43 PM ESTUpdated 06:43 PM
China
Pharma
Law

Law­mak­ers call for 'line in the sand' be­tween US and Chi­nese biotech com­pa­nies

Nicole DeFeudis

Editor

De­moc­rats and Re­pub­li­cans on the House Se­lect Com­mit­tee on the Chi­nese Com­mu­nist Par­ty railed against Chi­nese biotech com­pa­nies in a Thurs­day hear­ing on na­tion­al se­cu­ri­ty …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Up­dat­ed: With cost-cut­ting un­der­way, Bris­tol My­ers rais­es guid­ance, touts Phase 3 win and scraps an­oth­er

Among phar­ma CEOs, the IRA now and the IRA lat­er get very dif­fer­ent re­ac­tions

Bris­tol My­ers restarts ra­dio­phar­ma­ceu­ti­cal Phase 3 tri­al, but de­lays read­out by one year

An­drew Left, short sell­er who cam­paigned against Valeant, is ac­cused of fraud by SEC

Eu­ro­pean drug reg­u­la­tor re­jects Alzheimer's drug Leqem­bi, cit­ing safe­ty con­cerns

sponsored

Crit­i­cal Junc­tures in Gene Ther­a­py Clin­i­cal Ma­te­r­i­al Man­u­fac­tur­ing: Where Do I Start? And Will It Work?

A service from the Financial Times